Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05545735 · ClinicalTrials.gov registry record · Phase 4
The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days
A Phase 4 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 4
- Development phase
- 27
- Enrollment target
NCT05545735 is a Phase 4 study that was terminated before completion, run by University of Miami. The registered enrollment target is 27 participants.
The verdict
NCT05545735, a Phase 4 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the amount of antibiotics given for ventilator-associated pneumonia (VAP) can be decreased in order to reduce the risk of adverse effects associated with antibiotics, while at the same time ensuring the participant's safety.
Interventions
- DRUG Standard of Care Antibiotic Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2025-02-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05545735
The ClinicalTrials.gov registry entry for NCT05545735 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of Care Antibiotic Therapy is the first listed.
NCT05545735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05545735 about?
NCT05545735 is a clinical study titled "The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days". The purpose of this study is to see if the amount of antibiotics given for ventilator-associated pneumonia (VAP) can be decreased in order to reduce the risk of adverse effects associated with antibiotics, while at the same time ensuring the participant's safety.
What is the current status of trial NCT05545735?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 27 participants. The study started on 2023-05-08. Estimated completion is 2025-02-27.
What interventions are being tested in trial NCT05545735?
The interventions under investigation include: Standard of Care Antibiotic Therapy (DRUG).
Who is sponsoring clinical trial NCT05545735?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.